Researchers from Washington DC recently analyzed the increase in drug resistance, finding a growing public health threat that the scientists say must be addressed by pharmaceutical companies. The scientists analyzed data from 300 hospitals around the country that showed the bacteria Acinetobacter has become increasingly more resistant to the powerful antibiotic imipenem, marketed under the brand name Primaxin.
Acinetobacter is an infection found in hospitals in intensive care units causing pneumonia and sepsis (infection in the bloodstream). The bacteria is difficult to treat and at times unresponsive to any antibiotic. It has also been noted that soldiers returning from Iraq have been infected with Acinetobacter causing severe pneumonia and bloodstream infection.
• Toronto teen’s tragic death put face on H1N1 pandemic (Link)
• China treats severe swine flu patients with plasma harvested from recovered, vaccinated people (Link)
• Seasonal death toll from influenza, respiratory infections in Ukraine is 615(Link)
• Tire changer for Kevin Harvick’s team dies from H1N1 complications (Link)
• New Seasonal Flu Vaccine For Seniors (Link)
• Forty Percent Of Americans Will Change Holiday Plans Due To H1N1 Virus (Link)